AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Denali Therapeutics Inc.
$18.94
+$2.67 (+16.41%)
Previous Close
$19.32
Day Range
$18.64$19.63
Year Range
$13.75$27.30
Market Cap
3.03B
AVG Volume
1.66M
Trailing/Forward PE
-6.67/-
PEG ratio
0.28
Dividend Yield
-
Next Earnings Date
2026-11-03
Primary Exchange
NASDAQ
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Earnings: DNLI
Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 3 Nov 2026.
Video analysis: DNLI
All videosNo video analysis for this stock yet. Request one from our team.
News: DNLI
Similar companies
-
Cognition Therapeutics, Inc.
CGTX
·
NASDAQ
Compare
-
Ionis Pharmaceuticals, Inc.
IONS
·
NASDAQ
Compare
-
Amylyx Pharmaceuticals, Inc.
AMLX
·
NASDAQ
Compare
-
Neumora Therapeutics, Inc. Common Stock
NMRA
·
NASDAQ
Compare
-
ProMIS Neurosciences, Inc.
PMN
·
NASDAQ
Compare
-
Rapport Therapeutics, Inc. Common Stock
RAPP
·
NASDAQ
Compare